Process for converting S-enantiomer to its racemic form

US11319277B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11319277-B2
Application numberUS-202016749519-A
CountryUS
Kind codeB2
Filing dateJan 22, 2020
Priority dateMar 17, 2016
Publication dateMay 3, 2022
Grant dateMay 3, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a novel process for converting the unwanted S enantiomer form to its useful raceme with respect to a 4-aminoindane derivative and to novel intermediates of said process.

First claim

Opening claim text (preview).

The invention claimed is: 1. A compound of Formula IV, wherein, R is selected from a C 1 -C 6 alkyl group or a C 6 -C 10 aryl group, these groups being optionally substituted with one or more of C 1 -C 6 alkyl groups and/or halogen atoms. 2. The compound of claim 1 , which is (R)-N-(7-fluoro-1,1,3-trimethyl-3-hydroxy-1H-indan-4-yl)acetamide. 3. The compound of claim 1 prepared by a process starting from Formula (II), which is (S)-7-fluoro-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-amine, and comprising the steps of: (a) acylating the (S)-7-fluoro-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-amine to obtain an indaneamide derivative; and (b) oxidizing said indaneamide derivative to obtain 3-hydroxyl indaneamide derivative. 4. The compound of claim 3 which is (R)-N-(7-fluoro-1,1,3-trimethyl-3-hydroxy-1H-indan-4-yl)acetamide.

Assignees

Inventors

Classifications

  • the other ring being five-membered, e.g. indane · CPC title

  • with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring · CPC title

  • with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring · CPC title

  • by reactions not involving the formation of carboxamide groups · CPC title

  • from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11319277B2 cover?
The present invention relates to a novel process for converting the unwanted S enantiomer form to its useful raceme with respect to a 4-aminoindane derivative and to novel intermediates of said process.
Who is the assignee on this patent?
Fmc Corp
What technology area does this patent fall under?
Primary CPC classification C07C209/70. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue May 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).